 |
市場調査レポート
商品コード
1448218
神経デバイスの世界市場規模、シェア、成長分析、製品別、エンドユーザー別 - 産業予測、2024年～2031年Global Neurology Devices Market Size, Share, Growth Analysis, By Product(Neurostimulation Devices, Neurosurgery Devices), By End User(Hospitals, Neurology Clinics) - Industry Forecast 2024-2031 |
||||||
| 神経デバイスの世界市場規模、シェア、成長分析、製品別、エンドユーザー別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
神経デバイスの世界市場規模は2022年に145億8,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは8.1%で、2023年の157億6,000万米ドルから2031年には293億9,000万米ドルに成長する見通しです。
てんかん、外傷性脳損傷、脊髄損傷、パーキンソン病、アルツハイマー病など、数多くの神経疾患が神経学機器の焦点であり、これらの疾患の特定、予防、治療を目的としています。神経疾患の患者の転帰と生活の質を向上させるためには、神経デバイスは不可欠です。この機器の目的は、神経疾患の診断と治療のための最先端の機器と技術を医療従事者に提供することです。これらのツールは、治療介入をサポートし、異常を特定し、症状の経過を追跡するのに役立ちます。早期診断と早期治療の促進に加えて、これらの技術は患者ケアを強化し、優れた臨床結果をもたらします。
神経疾患の罹患率が上昇し、早期診断に対する需要が高まった結果、市場は拡大しています。てんかんや脳卒中の有病率の増加により、神経機器に対するニーズが高まっています。さらに、患者の転帰を改善する効率的な診断・治療アプローチに対するニーズも高まっています。神経デバイスの高価な性質と、規制当局の認可を得るための厳しい要件が、市場の拡大をさらに妨げています。
さらに、この業界は技術の進歩や革新的な医療機器企業によって成長しています。患者の予後を改善し、正確な診断を提供する高度な機器へのニーズが高まっているため、開業医や研究者としては、常に新しい医療機器を調査する必要があります。医療機器産業拡大のための政府のイニシアチブ、ヘルスケア施設建設のための財政の増加、医療機器分野における研究開発活動の拡大は、すべて市場の成長に寄与しています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
神経デバイスの世界市場：製品別
- 市場概要
- 神経刺激装置
- 脳神経外科用機器
- 神経介入装置
- 脳脊髄液デバイス
- その他
神経デバイスの世界市場：エンドユーザー別
- 市場概要
- 病院
- 神経内科クリニック
- および外来診療センター
神経デバイスの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic（US）
- Abbott Laboratories（US）
- Boston Scientific Corporation（US）
- Koninklijke Philips N.V.（Netherlands）
- Siemens Healthineers AG（Germany）
- Stryker Corporation（US）
- GE Healthcare（US）
- Johnson & Johnson（US）
- Zimmer Biomet Holdings, Inc.（US）
- Nihon Kohden Corporation（Japan）
- Hitachi, Ltd.（Japan）
- Brainlab AG（Germany）
- Elekta AB（Sweden）
- LivaNova PLC（UK）
- Nevro Corp.（US）
- Natus Medical Incorporated（US）
- Penumbra, Inc.（US）
- Integra LifeSciences Holdings Corporation（US）
- Terumo Corporation（Japan）
- Neuropace, Inc.（US）
Global Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).
Numerous neurological conditions, including epilepsy, traumatic brain damage, spinal cord injury, Parkinson's disease, and Alzheimer's disease, are the focus of neurology devices, which are designed to identify, prevent, and cure these conditions. In order to improve patient outcomes and the quality of life for individuals with neurological illnesses, the neurology device is essential. The purpose of this gadget is to give medical practitioners cutting-edge instruments and technologies for the diagnosis and treatment of neurological conditions. These tools support therapeutic intervention, help identify anomalies, and track the course of the condition. In addition to facilitating early diagnosis and treatment, these technologies enhance patient care and yield superior clinical results.
The market is expanding as a result of the rising incidence of neurological disorders and the increased demand for early diagnosis. The need for neurological devices is growing due to the increased prevalence of epilepsy and stroke. Furthermore, there is a growing need for efficient diagnostic and therapeutic approaches that improve patient outcomes. The expensive nature of neurological devices and the strict requirements for obtaining regulatory clearances further impede market expansion.
Additionally, the industry is growing due to technological advancements and innovative medical device companies. As a medical practitioner and researcher, you should always be researching new medical devices because there is a growing need for advanced equipment that improve patient outcomes and provide precise diagnoses. The government's initiative to expand the medical device industry, the rise in finances for the construction of healthcare facilities, and the expansion of research and development activities in the medical device sector all contribute to the growth of the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices Market Beverage Packaging Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurology Devices Market Segmental Analysis
The product, end user, and geographic segments of the worldwide neurology devices market are separated out. The market is divided into product categories, including cerebrospinal fluid devices, neurosurgical devices, neurostimulation devices, and interventional neurology devices. The market is divided into ambulatory care centers, neurology clinics, and hospitals based on the end user. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.
Drivers of the Global Neurology Devices Market
The need for neurology devices is still being driven by the rising incidence of neurological conditions like epilepsy, Parkinson's disease, and Alzheimer's disease. The World Health Organization (WHO) states that millions of individuals worldwide suffer from neurological illnesses, which calls for cutting-edge treatment and diagnostic options.
Restraints in the Global Neurology Devices Market
The market for neurology devices is subject to stringent regulations, which include gaining permission from regulatory bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). For smaller producers, complying with these laws can be difficult and expensive, which could impede the expansion of the industry.
Market Trends of the Global Neurology Devices Market
Transition to Less Invasive Techniques In the discipline of neurology, there is a discernible shift toward minimally invasive methods. Benefits of minimally invasive procedures include fewer surgical problems, shorter hospital stays, and faster recuperation periods. The need for neurological devices that allow for precise manipulations with less tissue injury is being driven by this trend.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Neurology Devices Market by Product
- Market Overview
- Neurostimulation Devices
- Neurosurgery Devices
- Interventional Neurology Devices
- Cerebrospinal Fluid Devices
- and Others
Global Neurology Devices Market by End User
- Market Overview
- Hospitals
- Neurology Clinics
- and Ambulatory Care Centers
Global Neurology Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuropace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
